TUCSON, Ariz., Nov. 10 /PRNewswire/ — Medipacs, Inc., a Tucson based drug delivery device company, announced the appointment of David Swenson, RPh and Agustin Vilches, RPh to the company’s medical Advisory Board. Both Swenson and Vilches have pharmacy backgrounds and together have practiced in Hospital, Hospice and Home care settings.
David Swenson worked for fifteen years at Swedish Hospital Medical Center and the Fred Hutchinson Cancer Research Center in Seattle, WA, before joining the Pyxis management team soon after its founding, where David played a central role in developing the economic value proposition for their Medstation drug dispensing systems. David is a founder of IntelliDOT Corporation and serves as Chief Clinical Officer. IntelliDOT has developed and is marketing point of care patient and workflow systems which reduce medication, laboratory and other errors in hospitals. David is an expert in the area of drug delivery safety and in systems which reduce the rate of serious errors that extend length of stay, a significant cost to hospitals.
Agustin (Tino) Vilches is a registered pharmacist who founded Capitol Home Infusion, Inc. (CHI) in 1994, a business serving patients receiving their medications in alternate site settings. Tino was responsible for operations and reimbursement. Since the sale of CHI to Neighborcare/Omnicare in 2004, he has served as Hospice Account Manager whereby he manages all aspects of Hospice pharmacy services for the Washington DC region. He is an expert in evaluating drug delivery systems and methods in Hospice and Home care settings.
“David’s experience in hospital pharmacy, work flow, economic value analysis and drug delivery safety are central to Medipacs’ plans to deploy devices which reduce medication errors and reduce therapy costs while enhancing patient service quality. David brings an exceptional combination of customer and industry perspective to the Medipacs board of advisors. Complementing David’s Hospital experience, Tino’s Hospice and Home care clinical experience as well as his operations and reimbursement business experience expand our deep understanding of clinical practice from hospital to hospice to home and will inform Medipacs how best to deploy products which facilitate the transition of patients through various care settings. We are very pleased to have David and Tino recognize the value of our technology and join our team. Each has been involved in the delivery of small volume injectable drugs for many years and knows well the problems of current delivery methods. Like other pharmacists and nurses who have seen our devices, they believe Medipacs has a game changing technology,” said Mark McWilliams, CEO of Medipacs.
About Medipacs
Medipacs, Inc. is a Tucson based drug delivery device company with expertise in hydro gel polymers. It is developing advanced infusion technologies and is now focused on its first commercial application, a programmable disposable infusion device called a Mini-Infuser(TM). The company is located at the Arizona Center for Innovation. Please contact: Mark McWilliams 858-227-0569 [email protected]
Medipacs, Inc.
CONTACT: Mark McWilliams of Medipacs, Inc., +1-858-227-0569,[email protected]
Web site: http://www.medipacs.com/
Comments